Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Gergely

Showing results (11-20 of 35) with videos related to

Pageof 4
Sort By:
Annals of the New York Academy of Sciences|July 15, 2005
Detection of TT virus in patients with idiopathic inflammatory myopathiesPeter Gergely, Antal Blazsek, Katalin Dankó, et al.
Methods in Molecular Medicine|August 3, 2004
Apoptosis and mitochondrial dysfunction in lymphocytes of patients with systemic lupus erythematosusAndras Perl, Gyorgy Nagy, Peter Gergely, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 5, 2002
Persistent mitochondrial hyperpolarization, increased reactive oxygen intermediate production, and cytoplasmic alkalinization characterize altered IL-10 signaling in patients with systemic lupus erythematosusPeter Gergely, Brian Niland, Nick Gonchoroff, et al.
Experimental Dermatology|April 11, 2008
Searching for foreign antigens as possible triggering factors of autoimmunity: Torque Teno virus DNA prevalence is elevated in sera of patients with bullous pemphigoidAntal Blazsek, Palma Sillo, Norito Ishii, et al.
Nature Reviews. Immunology|March 5, 2025
Defining immune reset: achieving sustained remission in autoimmune diseasesTobias Junt, Thomas Calzascia, Elisabetta Traggiai, et al.
Arthritis and Rheumatism|January 31, 2002
Mitochondrial hyperpolarization and ATP depletion in patients with systemic lupus erythematosusPeter Gergely, Craig Grossman, Brian Niland, et al.
Autoimmunity|April 25, 2008
Molecular mimicry and immunomodulation by the HRES-1 endogenous retrovirus in SLEAndras Perl, Gyorgy Nagy, Agnes Koncz, et al.
Clinical Immunology (Orlando, Fla.)|May 17, 2005
Increased prevalence of transfusion-transmitted virus and cross-reactivity with immunodominant epitopes of the HRES-1/p28 endogenous retroviral autoantigen in patients with systemic lupus erythematosusPeter Gergely, Rudolf Pullmann, Christina Stancato, et al.
RMD Open|August 14, 2025
Efficacy, pharmacokinetics and safety of iscalimab (CFZ533) in patients with proliferative lupus nephritis: a randomised, double-blind, placebo-controlled, phase II studyNan Shen, Julia Weinmann-Menke, Ana Malvar, et al.
Inflammatory Intestinal Diseases|December 14, 2020
A Multicentre, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy, Safety, and Tolerability of the S1P Receptor Agonist KRP203 in Patients with Moderately Active Refractory Ulcerative ColitisHeinfried H Radeke, Jürgen Stein, Gert Van Assche, et al.
Pageof 4

Showing results (11-20 of 35) with videos related to

Sort By:
Pageof 4
Annals of the New York Academy of Sciences|July 15, 2005
Detection of TT virus in patients with idiopathic inflammatory myopathiesPeter Gergely, Antal Blazsek, Katalin Dankó, et al.
Methods in Molecular Medicine|August 3, 2004
Apoptosis and mitochondrial dysfunction in lymphocytes of patients with systemic lupus erythematosusAndras Perl, Gyorgy Nagy, Peter Gergely, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 5, 2002
Persistent mitochondrial hyperpolarization, increased reactive oxygen intermediate production, and cytoplasmic alkalinization characterize altered IL-10 signaling in patients with systemic lupus erythematosusPeter Gergely, Brian Niland, Nick Gonchoroff, et al.
Experimental Dermatology|April 11, 2008
Searching for foreign antigens as possible triggering factors of autoimmunity: Torque Teno virus DNA prevalence is elevated in sera of patients with bullous pemphigoidAntal Blazsek, Palma Sillo, Norito Ishii, et al.
Nature Reviews. Immunology|March 5, 2025
Defining immune reset: achieving sustained remission in autoimmune diseasesTobias Junt, Thomas Calzascia, Elisabetta Traggiai, et al.
Arthritis and Rheumatism|January 31, 2002
Mitochondrial hyperpolarization and ATP depletion in patients with systemic lupus erythematosusPeter Gergely, Craig Grossman, Brian Niland, et al.
Autoimmunity|April 25, 2008
Molecular mimicry and immunomodulation by the HRES-1 endogenous retrovirus in SLEAndras Perl, Gyorgy Nagy, Agnes Koncz, et al.
Clinical Immunology (Orlando, Fla.)|May 17, 2005
Increased prevalence of transfusion-transmitted virus and cross-reactivity with immunodominant epitopes of the HRES-1/p28 endogenous retroviral autoantigen in patients with systemic lupus erythematosusPeter Gergely, Rudolf Pullmann, Christina Stancato, et al.
RMD Open|August 14, 2025
Efficacy, pharmacokinetics and safety of iscalimab (CFZ533) in patients with proliferative lupus nephritis: a randomised, double-blind, placebo-controlled, phase II studyNan Shen, Julia Weinmann-Menke, Ana Malvar, et al.
Inflammatory Intestinal Diseases|December 14, 2020
A Multicentre, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy, Safety, and Tolerability of the S1P Receptor Agonist KRP203 in Patients with Moderately Active Refractory Ulcerative ColitisHeinfried H Radeke, Jürgen Stein, Gert Van Assche, et al.
Pageof 4